Published online Jun 16, 2023. doi: 10.12998/wjcc.v11.i17.4098
Peer-review started: March 10, 2023
First decision: April 26, 2023
Revised: April 30, 2023
Accepted: May 22, 2023
Article in press: May 22, 2023
Published online: June 16, 2023
Processing time: 93 Days and 16.1 Hours
Massive pulmonary embolism (PE) results in extremely high mortality rates. Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) can provide circulatory and oxygenation support and rescue patients with massive PE. However, there are relatively few studies of extracorporeal cardiopulmonary resuscitation (ECPR) in patients with cardiac arrest (CA) secondary to PE. The aim of the present study is to investigate the clinical use of ECPR in conjunction with heparin anticoagulation in patients with CA secondary to PE.
We report the cases of six patients with CA secondary to PE treated with ECPR in the intensive care unit of our hospital between June 2020 and June 2022. All six patients experienced witnessed CA whilst in hospital. They had acute onset of severe respiratory distress, hypoxia, and shock rapidly followed by CA and were immediately given cardiopulmonary resuscitation and adjunctive VA-ECMO therapy. During hospitalization, pulmonary artery computed tomography angiography was performed to confirm the diagnosis of PE. Through anticoagulation management, mechanical ventilation, fluid management, and antibiotic treatment, five patients were successfully weaned from ECMO (83.33%), four patients survived for 30 d after discharge (66.67%), and two patients had good neurological outcomes (33.33%).
For patients with CA secondary to massive PE, ECPR in conjunction with heparin anticoagulation may improve outcomes.
Core Tip: Massive pulmonary embolism (PE) remains the leading clinical cause of death. Unfortunately, relatively few new technologies are available to reduce the morbidity and mortality of massive PE. Anticoagulation therapy is still the gold standard treatment for PE. In this study, we report the clinical details of six patients with cardiac arrest secondary to massive PE treated with extracorporeal cardiopulmonary resuscitation (ECPR) in conjunction with heparin anticoagulation. Our findings suggest that the use of ECPR is feasible in this cohort of patients and may improve resuscitation success rate and neurologically intact survival.